-
-
-
-
-
-
-
Telix Reports $204M Revenue, Up 63% YOY
-
-
-
-
-
-
-
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
-
-
-
-
-
-
-
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
-
-
-
-
-
-
-
Telix to Showcase ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline Developments at SNMMI
-
-
-
-
-
-
-
Torchlight Innovations Closes Initial Public Offering
-
-
-
-
-
-
-
Telix Pharmaceuticals Selects Goodwin Biotechnology as Manufacturing Scale-up Partner
1,155,231 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

